Mark Jepson
About Mark Jepson
Mark Jepson is a Business Analyst and Product Owner with extensive experience in product management and delivery roles. He currently works at esynergy and HM Revenue & Customs, and has held various positions across multiple companies since 1999.
Work at Esynergy
Mark Jepson has been employed at Esynergy as a Business Analyst and Product Owner since 2022. In this role, he is responsible for analyzing business needs and managing product development processes. His work involves collaborating with various stakeholders to ensure that product requirements are met effectively.
Current Role at HM Revenue & Customs
In addition to his position at Esynergy, Mark Jepson has also been working at HM Revenue & Customs as a Business Analyst since 2022. His responsibilities include analyzing business processes and providing insights to improve operational efficiency within the organization.
Previous Experience in Business Analysis
Mark Jepson has extensive experience in business analysis, having worked in various roles across multiple organizations. He served as a Business Analyst at Pets at Home for six months in 2020, followed by a position as an Enterprise Business Analyst at Evri for ten months in 2021. His role at Appreciate Group PLC included responsibilities as a Solution Designer, where he combined business analysis, product management, and architectural skills.
Educational Background
Mark Jepson studied at the University of Manchester Institute of Science and Technology (UMIST), where he earned a Bachelor of Science (BSc) degree in Chemistry from 1992 to 1995. This educational background provides him with a strong analytical foundation that supports his work in business analysis and product management.
Leadership at MJ6 Technology Limited
Mark Jepson is the CEO and Founder of MJ6 Technology Limited, a position he has held since 2015. In this role, he leads the company in providing technology solutions, leveraging his extensive experience in product management and delivery to drive business success.